Difficulty: Medium
Average Score: 78%
Practice
Michael is on warfarin and has recently been found to have a genetic variation that increases his sensitivity to warfarin. His dose may need to be:
Correct answer
B
Rationale
Choice B is correct because a genetic variation (e.g., CYP2C9 or VKORC1 polymorphism) increasing warfarin sensitivity means less drug is needed to achieve anticoagulation, so the dose should be decreased to avoid bleeding risks. Choice A is incorrect as increasing the dose would heighten toxicity. Choice C is wrong because holding it entirely risks under-treatment, not adjustment. Choice D is incorrect since unchanged dosing ignores the genetic impact.